(Total Views: 568)
Posted On: 12/09/2022 2:47:19 PM
Post# of 148983
Thx Werner, good find! Again, biggest competitor is Trodelvy by Gilead which they bought in Sep 2020 for like 20 billion.
As for the CytoDyn: NeoImmune Tech listing, looks like a typo. I would love to be in bed with NeoImmuneTech after their bad Alzheimer's drug fiasco. That would get us some media attention. The only thing wrong with Aduhelm, like Ivermectin, is it didn't work. Imagine if you had a drug that did work in that situation.
As for the CytoDyn: NeoImmune Tech listing, looks like a typo. I would love to be in bed with NeoImmuneTech after their bad Alzheimer's drug fiasco. That would get us some media attention. The only thing wrong with Aduhelm, like Ivermectin, is it didn't work. Imagine if you had a drug that did work in that situation.
(1)
(0)Scroll down for more posts ▼
